IMUX
IMUX
NASDAQ · Biotechnology

Immunic Inc

$1.20
+0.09 (+8.11%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +1,957.5% upside
Low Target $14.59
Average Target $24.69
High Target $25.91
Current Price $1.20
Current
$1.20
Target
$24.69
$14.59 $24.69 avg $25.91
Scenario Analysis
Bear Case
$14.59
1,115.8%
Low target
Base Case
$24.69
+1,957.5%
Avg target
Bull Case
$25.91
+2,059.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$1.51
-20.5% from high
52-Week Low
$0.51
+137.1% from low
Target vs 52W High
$24.69
+1,535.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%